Perspectives from CVM
Insights from CVM leadership and experts on current issues and actions.
CVM Antimicrobial Stewardship in FY 2023 and Beyond
By Bill Flynn, DVM, MS, Deputy Director of FDA’s Center for Veterinary Medicine
Today, we kick off Antimicrobial Awareness Week, held every year from November 18-24. This recognition is a great opportunity to reflect upon what we at FDA’s Center for Veterinary Medicine (CVM) are doing to address antimicrobial resistance (AMR) and preserve the effectiveness of these critical and life-saving drugs. In this post, I’m mainly going to focus on what we accomplished in FY 2023.
CVM One Health: Protecting Human, Animal and Environmental Health through a Strong Animal and Veterinary Industry
By: Tristan Colonius, DVM, MPA, DACVPM, Chief Veterinary Officer & Deputy Director for Science Policy at FDA’s Center for Veterinary Medicine
On Global One Health Day, we find ourselves at a time where modern technology creates possibilities we could only have dreamed of just a few years ago. Reflecting on the challenges of the pandemic, increasing temperatures across the world, disruptions in global supply chains and commerce, and the ever-present threat of zoonotic disease, it’s more important than ever that CVM embrace innovation. This is the key to supporting a more resilient and robust food production system, helping ensure food-producing animals and their environments are healthier and hardier, and addressing increasing animal health challenges such as zoonotic and animal infectious disease threats.
What We’re Doing to Stop Illicit Xylazine from Getting into the U.S.
By: Tracey Forfa, J.D., Director of FDA’s Center for Veterinary Medicine
You may have read or heard reports lately about xylazine, a chemical now being found in the human illicit drug supply. I’d like to catch up with you about this chemical and what the FDA’s Center for Veterinary Medicine is doing to address the situation.